my 5445 and trequinsin
my 5445 has been researched along with trequinsin in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Beretz, A; Cazenave, JP; Corre, G; Lanza, F; Stierlé, A | 1 |
| Bonnet, PA; Chevillard, C; Michel, A; Vittet, D; Zurbonsen, K | 1 |
Other Studies
2 other study(ies) available for my 5445 and trequinsin
| Article | Year |
|---|---|
Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Alprostadil; Aminoquinolines; Blood Platelets; Calcium; Cyclic AMP; Cytoplasm; Humans; Isoquinolines; Phthalazines; Platelet Aggregation; Quercetin; Quinazolines; Quinolines; Quinolones; Tetrahydroisoquinolines | 1987 |
Dissociation between phosphodiesterase inhibition and antiproliferative effects of phosphodiesterase inhibitors on the Dami cell line.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Alprostadil; Cell Division; Cyclic AMP; Humans; Isoenzymes; Isoquinolines; L-Lactate Dehydrogenase; Leukemia, Megakaryoblastic, Acute; Milrinone; Phosphodiesterase Inhibitors; Phthalazines; Pyridones; Pyrrolidinones; Rolipram; Tetrahydroisoquinolines; Tumor Cells, Cultured | 1997 |